Health ❯ Healthcare ❯ Patient Care

Chronic Conditions

Diabetes Management Obesity Management Heart Disease Hypertension Diabetes Type 2 Diabetes Obesity Autoimmune Diseases Management Strategies Resistant Hypertension

For Third Time, FDA Rejects Aldeyra’s Dry-Eye Drug Reproxalap Over Efficacy

Aldeyra plans a Type A meeting instead of new trials after the agency raised no safety or manufacturing issues.

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

FDA Approves J&J’s Icotyde, First Oral IL-23 Receptor Blocker for Plaque Psoriasis

Senseonics Reports Sustained Yearlong Real-World Performance for Eversense 365

New U.S. Cholesterol Guideline Shifts Prevention Earlier, Endorses PREVENT and Clear LDL Goals

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

Beta Bionics Beats Q4 Estimates, Sets 2026 Guidance With Pharmacy-Channel Targets

BIOPREVENT, a Biomarker‑AI Tool, Predicts Post‑Transplant cGVHD and Mortality Months Early

FDA Rejects Disc Medicine’s Bitopertin for EPP After Questioning Surrogate Endpoint

MRI T2 Mapping Yields Non-Invasive Measure of Heart Failure Severity, Study Finds

Germany Declares Shortage of Key Injectable Penicillin, Allows Temporary Imports

UK Pharmacies Ration Aspirin as Shortages Deepen, Prices Soar

Apple Watch Screening Quadruples AFib Detection in High-Risk Seniors, EQUAL RCT Finds

Liraglutide Patent Expiry Triggers Cheaper Weight‑Loss Generics in Germany

Experimental Vaccine NOUS-209 Shows Early Promise in Preventing Colon Cancer in Lynch Syndrome

FDA Clears Medtronic’s MiniMed Go App Linking InPen With Abbott’s Instinct CGM

Oxford Review Finds Rapid Weight Regain After Stopping GLP-1 Drugs

Trump Defends Health, Blames Bruises on High-Dose Aspirin, Denies Dozing Off

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

Vigo Hospitals Back to 95% Capacity as Cunqueiro ER Tops 600 Patients Again